会員登録
ログイン
【4541】日医工
〔上場廃止〕
ー(上場廃止)ジェネリック医薬品。
類似企業：
【業界1位】
東和薬品
【業界1位】
東和薬品
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022.03 | 2022/02/14 | Q3予 | 185,000 | → | 0.0% | -5.1% | -17,100 | → | 0.0% | -3520.0% | - | - | - | - | -18,600 | → | 0.0% | -9400.0% |
| 2022.03 | 2021/11/12 | Q2予 | 185,000 | → | 0.0% | -5.1% | -17,100 | → | 0.0% | -3520.0% | - | - | - | - | -18,600 | → | 0.0% | -9400.0% |
| 2022.03 | 2021/11/11 | 修正予 | 185,000 | ↓ | -5.1% | -5.1% | -17,100 | ↓ | -3520.0% | -3520.0% | - | - | - | - | -18,600 | ↓ | -9400.0% | -9400.0% |
| 2022.03 | 2021/08/10 | 当初予 | 195,000 | - | - | - | 500 | - | - | - | - | - | - | - | 200 | - | - | - |
| 2021.03 | 2021/05/14 | 実 | 188,218 | ↑ | +0.1% | -5.4% | 107 | ↑ | +7.0% | -98.6% | 1,068 | - | - | - | -4,179 | ↑ | +0.5% | -180.4% |
| 2021.03 | 2021/05/13 | 修正予 | 188,000 | ↓ | -5.5% | -5.5% | 100 | ↓ | -98.7% | -98.7% | - | - | - | - | -4,200 | ↓ | -180.8% | -180.8% |
| 2021.03 | 2020/08/11 | Q1予 | 199,000 | → | 0.0% | 0.0% | 7,500 | → | 0.0% | 0.0% | - | - | - | - | 5,200 | → | 0.0% | 0.0% |
| 2021.03 | 2020/05/18 | 当初予 | 199,000 | - | - | - | 7,500 | - | - | - | - | - | - | - | 5,200 | - | - | - |
| 2020.03 | 2020/05/18 | 実 | 190,076 | ↓ | -2.0% | -5.4% | 2,873 | ↓ | -66.2% | -66.2% | 7,396 | - | - | - | 5,133 | ↓ | -14.4% | -26.7% |
| 2020.03 | 2020/02/14 | Q3予 | 194,000 | → | 0.0% | -3.5% | 8,500 | → | 0.0% | 0.0% | - | - | - | - | 6,000 | → | 0.0% | -14.3% |
| 2020.03 | 2019/11/12 | Q2予 | 194,000 | ↓ | -3.5% | -3.5% | 8,500 | → | 0.0% | 0.0% | - | - | - | - | 6,000 | ↓ | -14.3% | -14.3% |
| 2020.03 | 2019/08/09 | Q1予 | 201,000 | → | 0.0% | 0.0% | 8,500 | → | 0.0% | 0.0% | - | - | - | - | 7,000 | → | 0.0% | 0.0% |
| 2020.03 | 2019/05/13 | 当初予 | 201,000 | - | - | - | 8,500 | - | - | - | - | - | - | - | 7,000 | - | - | - |
| 2019.03 | 2019/05/13 | 実 | 166,592 | ↓ | -2.0% | -3.1% | 8,223 | ↓ | -13.4% | +2.8% | 8,903 | - | - | - | 6,864 | ↓ | -1.9% | +37.3% |
| 2019.03 | 2019/02/12 | Q3予 | 170,000 | → | 0.0% | -1.2% | 9,500 | → | 0.0% | +18.8% | - | - | - | - | 7,000 | → | 0.0% | +40.0% |
| 2019.03 | 2018/11/09 | Q2予 | 170,000 | → | 0.0% | -1.2% | 9,500 | → | 0.0% | +18.8% | - | - | - | - | 7,000 | → | 0.0% | +40.0% |
| 2019.03 | 2018/11/07 | 修正予 | 170,000 | ↓ | -1.2% | -1.2% | 9,500 | ↑ | +18.8% | +18.8% | - | - | - | - | 7,000 | ↑ | +40.0% | +40.0% |
| 2019.03 | 2018/05/14 | 当初予 | 172,000 | - | - | - | 8,000 | - | - | - | - | - | - | - | 5,000 | - | - | - |
| 2018.03 | 2018/05/14 | 実 | 164,717 | ↓ | -17.6% | -20.0% | 10,301 | ↑ | +14.5% | +14.5% | 9,067 | ↑ | +5.4% | +5.4% | 8,070 | ↑ | +46.7% | +46.7% |
| 2018.03 | 2018/02/07 | Q3予 | 200,000 | → | 0.0% | -2.9% | 9,000 | → | 0.0% | 0.0% | 8,600 | → | 0.0% | 0.0% | 5,500 | → | 0.0% | 0.0% |
| 2018.03 | 2017/11/08 | Q2予 | 200,000 | ↓ | -2.9% | -2.9% | 9,000 | → | 0.0% | 0.0% | 8,600 | → | 0.0% | 0.0% | 5,500 | → | 0.0% | 0.0% |
| 2018.03 | 2017/08/09 | Q1予 | 206,000 | → | 0.0% | 0.0% | 9,000 | → | 0.0% | 0.0% | 8,600 | → | 0.0% | 0.0% | 5,500 | → | 0.0% | 0.0% |
| 2018.03 | 2017/05/10 | 当初予 | 206,000 | - | - | - | 9,000 | - | - | - | 8,600 | - | - | - | 5,500 | - | - | - |
| 2017.03 | 2017/05/10 | 実 | 163,372 | ↓ | -2.2% | +2.7% | 8,554 | ↑ | +29.6% | -39.8% | 8,411 | ↑ | +47.6% | -40.8% | 4,788 | ↑ | +99.5% | -46.8% |
| 2017.03 | 2017/02/08 | Q3予 | 167,000 | → | 0.0% | +5.0% | 6,600 | → | 0.0% | -53.5% | 5,700 | → | 0.0% | -59.9% | 2,400 | → | 0.0% | -73.3% |
| 2017.03 | 2016/11/07 | Q2予 | 167,000 | ↑ | +5.0% | +5.0% | 6,600 | ↓ | -53.5% | -53.5% | 5,700 | ↓ | -59.9% | -59.9% | 2,400 | ↓ | -73.3% | -73.3% |
| 2017.03 | 2016/05/10 | 当初予 | 159,000 | - | - | - | 14,200 | - | - | - | 14,200 | - | - | - | 9,000 | - | - | - |
| 2016.03 | 2016/05/10 | 実 | 143,513 | ↑ | +2.5% | +4.6% | 12,910 | ↑ | +3.3% | +3.3% | 12,289 | ↑ | +1.6% | +1.6% | 11,031 | ↑ | +0.3% | +37.9% |
| 2016.03 | 2016/02/09 | Q3予 | 140,000 | → | 0.0% | +2.0% | 12,500 | → | 0.0% | 0.0% | 12,100 | → | 0.0% | 0.0% | 11,000 | ↑ | +37.5% | +37.5% |
| 2016.03 | 2015/11/04 | Q2予 | 140,000 | ↑ | +2.0% | +2.0% | 12,500 | → | 0.0% | 0.0% | 12,100 | → | 0.0% | 0.0% | 8,000 | → | 0.0% | 0.0% |
| 2016.03 | 2015/08/10 | Q1予 | 137,200 | → | 0.0% | 0.0% | 12,500 | → | 0.0% | 0.0% | 12,100 | → | 0.0% | 0.0% | 8,000 | → | 0.0% | 0.0% |
| 2016.03 | 2015/05/12 | 当初予 | 137,200 | - | - | - | 12,500 | - | - | - | 12,100 | - | - | - | 8,000 | - | - | - |
| 2015.03 | 2015/05/12 | 実 | 127,021 | ↑ | +3.3% | +3.3% | 9,619 | ↑ | +3.4% | +3.4% | 9,615 | ↑ | +6.8% | +6.8% | 6,592 | ↑ | +11.7% | +11.7% |
| 2015.03 | 2015/02/12 | Q3予 | 123,000 | → | 0.0% | 0.0% | 9,300 | → | 0.0% | 0.0% | 9,000 | → | 0.0% | 0.0% | 5,900 | → | 0.0% | 0.0% |
| 2015.03 | 2014/11/05 | Q2予 | 123,000 | → | 0.0% | 0.0% | 9,300 | → | 0.0% | 0.0% | 9,000 | → | 0.0% | 0.0% | 5,900 | → | 0.0% | 0.0% |
| 2015.03 | 2014/08/11 | Q1予 | 123,000 | → | 0.0% | 0.0% | 9,300 | → | 0.0% | 0.0% | 9,000 | → | 0.0% | 0.0% | 5,900 | → | 0.0% | 0.0% |
| 2015.03 | 2014/05/12 | 当初予 | 123,000 | - | - | - | 9,300 | - | - | - | 9,000 | - | - | - | 5,900 | - | - | - |
| 2014.03 | 2014/05/12 | 実 | 103,622 | - | - | - | 7,383 | - | - | - | 7,085 | - | - | - | 4,588 | - | - | - |
